CollPlant Biotechnologies Ltd (CLGN) Net margin 2018–2025
CollPlant Biotechnologies Ltd (CLGN) net profit margin by fiscal year — reported net income divided by reported revenue.
-484.6%FY2025 · since FY2018: -124.6% → -484.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -484.6% | +2740.5 pp |
| FY2024 | -3225.0% | -3161.0 pp |
| FY2023 | -64.0% | +5596.5 pp |
| FY2022 | -5660.5% | -5662.1 pp |
| FY2021 | 1.5% | +95.6 pp |
| FY2020 | -94.1% | +387.5 pp |
| FY2019 | -481.6% | -357.0 pp |
| FY2018 | -124.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CLGN financial trends
CLGN RevenueCLGN Net incomeCLGN Gross profitCLGN Gross marginCLGN Operating incomeCLGN Operating marginCLGN Operating cash flowCLGN Free cash flowCLGN Capital expendituresCLGN Return on equityCLGN Stock buybacksCLGN Dividends paidCLGN Total assetsCLGN Total liabilitiesCLGN Shareholders’ equityCLGN overview →